OMER (STOCKS)
Omeros Corporation
$9.320000
+0.585000 (+6.70%)
Prev close: $8.735000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Gregory A. Demopulos
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $674.54M
- Employees
- 202
- P/E (TTM)
- 10.90
- P/B (TTM)
- -10.61
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
4
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.24 | $-0.41 | +0.1731 | +41.90% |
|
Dec 2025 (Q4)
|
$0.98 | $-0.58 | +1.5614 | +268.56% |
|
Sep 2025 (Q3)
|
$-0.47 | $-0.45 | -0.0161 | -3.55% |
|
Jun 2025 (Q2)
|
$-0.43 | $-0.49 | +0.0606 | +12.35% |
Financial Statements
| Revenues | $9.89M |
| Costs And Expenses | $115.14M |
| Selling, General, and Administrative Expenses | $43.75M |
| Research and Development | $70.81M |
| Operating Income/Loss | -$105.25M |
| Income/Loss From Continuing Operations After Tax | $84.01M |
| Income/Loss From Continuing Operations Before Tax | $86.54M |
| Income/Loss From Discontinued Operations Net Of Tax | $2.16M |
| Income Tax Expense/Benefit | $2.07M |
| Net Income/Loss | $86.17M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $86.17M |
| Net Income/Loss Available To Common Stockholders, Basic | $86.17M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.30 |
| Diluted Earnings Per Share | $1.14 |
| Basic Average Shares | 199,226,570 |
| Assets | $286.17M |
| Current Assets | $180.36M |
| Accounts Receivable | $12.03M |
| Inventory | $183.00K |
| Other Current Assets | $168.14M |
| Noncurrent Assets | $105.82M |
| Fixed Assets | $1.53M |
| Other Non-current Assets | $104.29M |
| Liabilities | $349.51M |
| Current Liabilities | $59.44M |
| Accounts Payable | $5.37M |
| Wages | $9.74M |
| Other Current Liabilities | $44.34M |
| Noncurrent Liabilities | $290.06M |
| Equity | -$63.33M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$63.33M |
| Liabilities And Equity | $286.17M |
| Net Cash Flow From Operating Activities | -$94.76M |
| Net Cash Flow From Operating Activities, Continuing | -$94.76M |
| Net Cash Flow From Investing Activities | $154.72M |
| Net Cash Flow From Investing Activities, Continuing | $154.72M |
| Net Cash Flow From Financing Activities | -$62.31M |
| Net Cash Flow From Financing Activities, Continuing | -$62.31M |
| Net Cash Flow | -$2.36M |
| Net Cash Flow, Continuing | -$2.36M |
| Comprehensive Income/Loss | $86.17M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $86.17M |
| Other Comprehensive Income/Loss | $0.00 |